GENENTA SCIENCE(SP.ADR)/1 (K5F) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.68x
GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Cash Flow-to-Debt Ratio of -0.68x as of December 2025, meaning its operating cash flow of €-6.87 Million could theoretically repay -1% of its total liabilities (€10.05 Million) in one year. See GENENTA SCIENCE(SP.ADR)/1 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.68x
Operating CF / Total Liabilities
Operating Cash Flow
€-6.87 Million
EUR
Total Liabilities
€10.05 Million
EUR
Data as of
Dec 2025
Most recent filing
GENENTA SCIENCE(SP.ADR)/1 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for GENENTA SCIENCE(SP.ADR)/1 across 5 annual periods. For the full cash flow conversion analysis, see GENENTA SCIENCE(SP.ADR)/1 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)
Year-by-year debt coverage analysis for GENENTA SCIENCE(SP.ADR)/1.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | €-6.87 Million | €10.05 Million | ▲ +74.5% |
| 2024 | -2.68x | €-6.24 Million | €2.33 Million | ▲ +54.2% |
| 2023 | -5.85x | €-11.21 Million | €1.91 Million | ▼ -81.4% |
| 2022 | -3.23x | €-7.42 Million | €2.30 Million | ▲ +46.0% |
| 2021 | -5.97x | €-6.96 Million | €1.17 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.